>>> US Research Calls

Research Calls
  • Upgrades:
    • Air Products (APD) upgraded to Buy from Neutral at BofA Securities; tgt $264
    • Coinbase Global (COIN) upgraded to Neutral from Underweight at JP Morgan; tgt $80
    • Eversource Energy (ES) upgraded to Buy from Neutral at Mizuho; tgt raised to $62
    • Ingredion (INGR) upgraded to Buy from Neutral at Goldman; tgt raised to $135
    • Inogen (INGN) upgraded to Outperform from Mkt Perform at William Blair
    • Medpace (MEDP) upgraded to Buy from Neutral at UBS; tgt raised to $452
    • Molina Healthcare (MOH) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $420
    • Principal Fincl (PFG) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt $75
    • Similarweb (SMWB) upgraded to Buy from Neutral at Citigroup; tgt raised to $10
    • Teradyne (TER) upgraded to Neutral from Underweight at JP Morgan; tgt raised to $100
  • Downgrades:
    • Akamai Tech (AKAM) downgraded to Reduce from Hold at HSBC Securities; tgt lowered to $96
    • Cleveland-Cliffs (CLF) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $20
    • Comcast (CMCSA) downgraded to Neutral from Buy at Redburn Atlantic; tgt lowered to $44
    • Charles River (CRL) downgraded to Neutral from Buy at Guggenheim
    • Generac (GNRC) downgraded to Neutral from Buy at Guggenheim
    • IQVIA (IQV) downgraded to Neutral from Buy at Guggenheim
    • Keysight (KEYS) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $170
    • Owens Corning (OC) downgraded to In-line from Outperform at Evercore ISI; tgt lowered to $154
    • Snowflake (SNOW) downgraded to Hold from Buy at HSBC Securities; tgt raised to $214
    • Sony (SONY) downgraded to Neutral from Outperform at Macquarie
    • SSR Mining (SSRM) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $6
    • U.S. Steel (X) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $51
    • Wabtec (WAB) downgraded to Neutral from Buy at Redburn Atlantic; tgt $135
  • Others:
    • Alnylam Pharma (ALNY) initiated with a Peer Perform at Wolfe Research
    • Alpine Immune Sciences (ALPN) initiated with an Outperform at Wolfe Research; tgt $44
    • argenx (ARGX) initiated with a Peer Perform at Wolfe Research
    • CervoMed (CRVO) initiated with a Buy at Canaccord Genuity; tgt $50
    • Cisco (CSCO) resumed with an Equal Weight at Wells Fargo; tgt $52
    • CRISPR Therapeutics (CRSP) initiated with a Peer Perform at Wolfe Research
    • Cullinan Management (CGEM) initiated with an Outperform at Wedbush; tgt $30
    • Deckers Outdoor (DECK) initiated with an Outperform at Evercore ISI; tgt $960
    • Dianthus Therapeutics (DNTH) initiated with a Buy at Stifel; tgt $44
    • Eastman Chemical (EMN) initiated with a Buy at Redburn Atlantic; tgt $110
    • Elastic (ESTC) initiated with a Sector Outperform at Scotiabank; tgt $185
    • GE HealthCare (GEHC) initiated with a Buy at HSBC Securities; tgt $100
    • i3 Verticals (IIIV) added to DA Davidson's Stampede List
    • Immunovant Sciences (IMVT) initiated with an Outperform at Wolfe Research; tgt $55
    • Insmed (INSM) initiated with an Outperform at Wolfe Research; tgt $42
    • Intellia Therapeutics (NTLA) initiated with a Peer Perform at Wolfe Research
    • JELD-WEN (JELD) initiated with a Hold at Loop Capital; tgt $22
    • Kymera Therapeutics (KYMR) initiated with a Peer Perform at Wolfe Research
    • MoonLake Immunotherapeutics (MLTX) initiated with an Outperform at Wolfe Research; tgt $77
    • Monte Rosa Therapeutics (GLUE) initiated with an Outperform at Wedbush; tgt $11
    • RAPT Therapeutics (RAPT) initiated with an Outperform at Wolfe Research; tgt $39
    • Roivant Sciences (ROIV) initiated with an Outperform at Wolfe Research; tgt $17
    • Savara (SVRA) initiated with a Mkt Outperform at JMP Securities; tgt $8
    • Skechers USA (SKX) initiated with an Outperform at Evercore ISI; tgt $73
    • Super Micro Computer (SMCI) initiated with a Buy at BofA Securities; tgt $1040
    • Vertex Pharma (VRTX) initiated with an Outperform at Wolfe Research; tgt $515